cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Harmony Biosciences Holdings Inc
10 own
4 watching
Current Price
$36.27
$0.55
(1.54%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
2,157.77M
52-Week High
52-Week High
62.08500
52-Week Low
52-Week Low
29.81000
Average Volume
Average Volume
1.47M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
142.9976
iconMarket Capitalization2,157.77M
icon52-Week High62.08500
icon52-Week Low29.81000
iconAverage Volume1.47M
iconDividend Yield--
iconP/E Ratio142.9976
What does the Harmony Biosciences Holdings Inc do?
We are a commercial-stage pharmaceutical company focused on developing and commercializing innovative therapies for patients living with rare neurological disorders who have unmet medical needs. --- Our corporate headquarters are located at 630 W. Germantown Pike, Suite 215, Plymouth Meeting, Pennsylvania 19462. Our telephone number is (484) 539-9800. Our principal website address is www.harmonybiosciences.com.
Read More
How much money does Harmony Biosciences Holdings Inc make?
News & Events about Harmony Biosciences Holdings Inc.
Globe Newswire
3 months ago
NEW YORK, June 19, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Techtronic Industries Company Limited (OTC Pink: TTNDY), Boxed, Inc. (NYSE: BOXD), Coinbase Global, Inc. (NASDAQ: COIN), and Harmony...
Globe Newswire
5 months ago
NEW YORK, April 23, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against LivePerson, Inc. (NASDAQ: LPSN), and Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY). Our investigations concern whether these ...
Globe Newswire
5 months ago
SAN FRANCISCO, April 20, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) investors who suffered substantial losses to submit your losses now. Visit: www.hbsslaw.com/investor-fraud/HRMY Contact An Attorney Now: HRMY@hbsslaw.com 844-916-0895 Harmony ...
Globe Newswire
5 months ago
NEW YORK, April 12, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against LivePerson, Inc. (NASDAQ: LPSN), and Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY). Our investigations concern whether these ...
Globe Newswire
5 months ago
SAN FRANCISCO, April 11, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) investors who suffered substantial losses to submit your losses now. Visit: www.hbsslaw.com/investor-fraud/HRMY Contact An Attorney Now: HRMY@hbsslaw.com 844-916-0895 Harmony ...
Frequently Asked Questions
Frequently Asked Questions
What is Harmony Biosciences Holdings Inc share price today?
plus_minus_icon
Can Indians buy Harmony Biosciences Holdings Inc shares?
plus_minus_icon
How can I buy Harmony Biosciences Holdings Inc shares from India?
plus_minus_icon
Can Fractional shares of Harmony Biosciences Holdings Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Harmony Biosciences Holdings Inc stocks?
plus_minus_icon
What is today’s traded volume of Harmony Biosciences Holdings Inc?
plus_minus_icon
What is today’s market capitalisation of Harmony Biosciences Holdings Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Harmony Biosciences Holdings Inc?
plus_minus_icon
What percentage is Harmony Biosciences Holdings Inc down from its 52-Week High?
plus_minus_icon
What percentage is Harmony Biosciences Holdings Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$36.27
$0.55
(1.54%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
SpringWorks Therapeutics Inc
SpringWorks Therapeutics Inc
$23.72
$-0.42 (-1.74 %)
Immunovant Inc
Immunovant Inc
$20.38
$-0.87 (-4.09 %)
Morphic Holding Inc
Morphic Holding Inc
$36.72
$-14.68 (-28.56 %)
Arcus Biosciences Inc
Arcus Biosciences Inc
$19.72
$-0.66 (-3.24 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
SpringWorks Therapeutics Inc
SpringWorks Therapeutics Inc
$23.72
$-0.42 (-1.74 %)
Immunovant Inc
Immunovant Inc
$20.38
$-0.87 (-4.09 %)
Morphic Holding Inc
Morphic Holding Inc
$36.72
$-14.68 (-28.56 %)
Arcus Biosciences Inc
Arcus Biosciences Inc
$19.72
$-0.66 (-3.24 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Foreside Fund Services acts as the distributor to the DriveWealth ICE 100 Index ETF and is not affiliated with Borderless Investing Inc, DriveWealth LLC, BlackOak Investors LP, ACR Group, or other entities referenced on this website.

              Get Started with as little as $1.00